Mitchell Hill

Array ( [id] => 4047352 [patent_doc_number] => 05968838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Antiarrhythmic peptide from venom of spider Grammostola spatulata' [patent_app_type] => 1 [patent_app_number] => 9/010204 [patent_app_country] => US [patent_app_date] => 1998-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6173 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968838.pdf [firstpage_image] =>[orig_patent_app_number] => 010204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4362950 [patent_doc_number] => 06287563 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Therapeutic agents and autoimmune diseases' [patent_app_type] => 1 [patent_app_number] => 8/999458 [patent_app_country] => US [patent_app_date] => 1997-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 12500 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287563.pdf [firstpage_image] =>[orig_patent_app_number] => 999458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4324196 [patent_doc_number] => 06312686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Modulating the permeability of a physiological barrier with an agent that modulates tyrosine phosphorylation' [patent_app_type] => 1 [patent_app_number] => 8/648182 [patent_app_country] => US [patent_app_date] => 1997-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 37 [patent_no_of_words] => 18342 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312686.pdf [firstpage_image] =>[orig_patent_app_number] => 648182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3951733 [patent_doc_number] => 05955575 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Antagonists of G-protein-coupled receptor' [patent_app_type] => 1 [patent_app_number] => 8/995927 [patent_app_country] => US [patent_app_date] => 1997-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4177 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955575.pdf [firstpage_image] =>[orig_patent_app_number] => 995927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4073571 [patent_doc_number] => 06069234 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Modified coagulation agent' [patent_app_type] => 1 [patent_app_number] => 8/994328 [patent_app_country] => US [patent_app_date] => 1997-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4004 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069234.pdf [firstpage_image] =>[orig_patent_app_number] => 994328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038946 [patent_doc_number] => 05874121 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Method of producing L-aspartyl-D-alanine-N-(thiethane-3-yl)-amides' [patent_app_type] => 1 [patent_app_number] => 8/894518 [patent_app_country] => US [patent_app_date] => 1997-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6402 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874121.pdf [firstpage_image] =>[orig_patent_app_number] => 894518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260583 [patent_doc_number] => 06258780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Method and composition for enabling passage through the blood-brain-barrier' [patent_app_type] => 1 [patent_app_number] => 8/975084 [patent_app_country] => US [patent_app_date] => 1997-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 15573 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258780.pdf [firstpage_image] =>[orig_patent_app_number] => 975084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3949341 [patent_doc_number] => 05955421 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-21 [patent_title] => 'Peptides containing D-2-alkyl-Tryptophan' [patent_app_type] => 1 [patent_app_number] => 8/971032 [patent_app_country] => US [patent_app_date] => 1997-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 29 [patent_no_of_words] => 13286 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/955/05955421.pdf [firstpage_image] =>[orig_patent_app_number] => 971032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1278488 [patent_doc_number] => 06645936 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Reducing postoperative astigmatism' [patent_app_type] => B1 [patent_app_number] => 08/945901 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1439 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/645/06645936.pdf [firstpage_image] =>[orig_patent_app_number] => 08945901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4102601 [patent_doc_number] => 06066715 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-23 [patent_title] => 'Ligands for phosphatase binding assay' [patent_app_type] => 1 [patent_app_number] => 8/964308 [patent_app_country] => US [patent_app_date] => 1997-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12713 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/066/06066715.pdf [firstpage_image] =>[orig_patent_app_number] => 964308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4086119 [patent_doc_number] => 06025331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-15 [patent_title] => 'Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis' [patent_app_type] => 1 [patent_app_number] => 8/961264 [patent_app_country] => US [patent_app_date] => 1997-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 12659 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/025/06025331.pdf [firstpage_image] =>[orig_patent_app_number] => 961264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3943385 [patent_doc_number] => 05990082 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Uses of lipopolysaccharide binding protein' [patent_app_type] => 1 [patent_app_number] => 8/955660 [patent_app_country] => US [patent_app_date] => 1997-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9939 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/990/05990082.pdf [firstpage_image] =>[orig_patent_app_number] => 955660 [rel_patent_id] =>[rel_patent_doc_number] =>)